TY  - GEN
AU  - Sureda,Anna
AU  - Canals,Carme
AU  - Arranz,Reyes
AU  - Caballero,Dolores
AU  - Ribera,Josep Maria
AU  - Brune,Mats
AU  - Passweg,Jacob
AU  - Martino,Rodrigo
AU  - Valcárcel,David
AU  - Besalduch,Joan
AU  - Duarte,Rafael
AU  - León,Angel
AU  - Pascual,Maria Jesus
AU  - García-Noblejas,Ana
AU  - López Corral,Lucia
AU  - Xicoy,Bianca
AU  - Sierra,Jordi
AU  - Schmitz,Norbert
TI  - Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
SN  - 1592-8721
PY  - 2012///0919
KW  - Adolescent
KW  - Adult
KW  - Europe
KW  - Female
KW  - Graft vs Host Disease
KW  - immunology
KW  - Hodgkin Disease
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Secondary Prevention
KW  - Stem Cell Transplantation
KW  - methods
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - mortality
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.3324/haematol.2011.045757
ER  -